Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections [Phase 2]
Phase 2 trial comparing liposomal amphotericin B (Ambisome) to oral voriconazole for prevention of invasive fungal infections in patients wi…
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: 5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS [Phase 2]
Phase 2 clinical trial evaluating the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and…
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS). [Phase 2]
This Phase 2 trial compares clofarabine alone versus clofarabine with low-dose cytarabine in previously untreated acute myeloid leukemia and…
-
FDA approval · 2011-04-26FDA Approved: MITOXANTRONE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for mitoxantrone hydrochloride from Fresenius Kabi USA, LLC. This approval encompasses the generic p…
-
CLINICAL_TRIALS research · 2011-04-26Clinical Trial Update: Development of a Diagnostic Kit for FLT3-ITD in Acute Myeloid Leukemia
Clinical trial update on the development of a diagnostic kit for FLT3-ITD mutation detection in acute myeloid leukemia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients [Phase 2]
Phase 2 trial evaluating azacitidine with valproic acid versus cytarabine in patients with acute myeloid leukemia or myelodysplastic syndrom…
-
CLINICAL_TRIALS withdrawal · 2011-04-08Clinical Trial Update: To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning [Phase 3]
A Phase 3 clinical trial evaluating adding Campath-1H (alemtuzumab) or ATG to fludarabine and low-dose busulfan conditioning for acute myelo…
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia [Phase 3]
Phase 3 trial update evaluating treatment for children and adolescents with refractory or relapsed acute myeloid leukemia; the study status …
-
CLINICAL_TRIALS research · 2011-04-06Clinical Trial Update: Functional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)
A clinical trial entry examining how RUNX1 mutations contribute to the etiology of acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2011-04-01Clinical Trial Update: A Risk-Oriented Therapeutic Strategy for Adult Acute Myelogenous Leukemia [Phase 2]
This update reports results from a Phase 2 trial evaluating a risk-oriented therapeutic strategy in adults with acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2011-03-29Clinical Trial Update: Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia [Phase 3]
A Phase 3 trial comparing cytarabine with arsenic trioxide versus cytarabine alone in elderly patients with acute myeloid leukemia was termi…
-
CLINICAL_TRIALS trial_result · 2011-03-24Clinical Trial Update: A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II) [Phase 2]
Phase 2 clinical trial update evaluating Clofarabine for older patients with newly diagnosed acute myeloid leukemia.
-
CLINICAL_TRIALS research · 2011-03-16Clinical Trial Update: Pre-hospital Risk Factors for Invasive Fungal Infection
This clinical trial update discusses pre-hospital risk factors for invasive fungal infections in patients with acute myeloid leukemia and re…
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 study evaluating all-trans retinoic acid and bryostatin in patients with acute myeloid leukemia and myelodysplastic syndromes has co…
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia [Phase 1]
Phase 1 clinical trial evaluating vaccination with autologous acute myeloid leukemia cells in adults with advanced myelodysplastic syndromes…
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia [Phase 1]
Phase 1 multicenter trial evaluating 9-aminocamptothecin (9-AC) in patients with refractory leukemia, including acute myeloid leukemia and a…
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: High Dose Ara-C (HDAC) and Interleukin-2 (IL-2) for Patients With Acute Myelogenous Leukemia (AML) [Phase 2]
A Phase 2 trial evaluating high-dose cytarabine (HDAC) with interleukin-2 (IL-2) for acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 2]
A Phase 2 trial evaluates combination chemotherapy followed by filgrastim or sargramostim in patients with relapsed or refractory acute myel…
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia [Phase 1]
Phase 1 study evaluating irinotecan and cytarabine in patients with refractory or recurrent acute myeloid leukemia or chronic myeloid leukem…
-
CLINICAL_TRIALS trial_result · 2011-02-14Clinical Trial Update: Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) [Phase 1, Phase 2]
A completed Phase I/II trial evaluating the combination of 5-azacytidine with cytarabine in patients with relapsed/refractory acute myeloid …
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
This is a Phase 2 clinical trial evaluating combination chemotherapy for newly diagnosed acute myeloid leukemia. The study, sponsored by The…
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome [Phase 1, Phase 2]
Phase 1/2 trial evaluating treosulfan with fludarabine as conditioning before donor stem cell transplant in younger patients with AML, ALL, …
-
CLINICAL_TRIALS trial_result · 2011-02-03Clinical Trial Update: Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting [Phase 2]
A Phase 2 randomized trial compared palonosetron to ondansetron for the prevention of chemotherapy-induced nausea and vomiting in patients w…
-
CLINICAL_TRIALS trial_result · 2011-02-02Clinical Trial Update: A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating AS1411 with cytarabine for primary refractory or relapsed acute myeloid leukemia was terminated.
-
CLINICAL_TRIALS trial_result · 2011-02-01Clinical Trial Update: A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia. [Phase 2]
Phase 2 study of the farnesyl transferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia. The trial sta…